Andere talen Invivyd, Inc.

Aandelen

IVVD

US00534A1025

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,42 ^USD	+9,01%		+6,61%	-38,58%

12/04	Invivyd benoemt Jeremy Gowler tot interim CEO	MT
12/04	Invivyd, Inc. Kondigt wijzigingen in leidinggevenden aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position	30/04
Invivyd Announces CEO TransitionJeremy Gowler appointed Interim CEO	15/04
INVIVYD ANNOUNCES CEO TRANSITION	15/04
Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™	15/04
Invivyd, Inc. Receives Healthcare Common Procedure Coding System Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services Covering Pemgarda	15/04
Invivyd Names Jeremy Gowler as Interim CEO	12/04
Invivyd, Inc. Announces Executive Changes	12/04
Invivyd Announces CEO Transition	12/04
Invivyd, Inc. Announces CEO Changes	12/04
North American Morning Briefing : Inflation Data, -2-	08/04
Invivyd's Pemgarda Injection to Prevent Covid Available in US -- Shares Rise After Hours	04/04
Invivyd Sees Covid-19 Prevention Treatment Revenue of Up to $200 Million This Year	04/04
Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million	04/04
Invivyd, Inc. Provides Earnings Guidance for the Year 2024	04/04
North American Morning Briefing : Focus Turns to -2-	04/04
Invivyd, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights	28/03
North American Morning Briefing : Stocks Edge -2-	27/03
Sector Update: Health Care Stocks Rise Tuesday Afternoon	26/03
Invivyd Clears Significant Hurdle After Pemgarda Authorization, Morgan Stanley Says	26/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Invivyd, Inc.

Aandelen

IVVD

US00534A1025

Andere talen

Filters